BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD

Similar documents
Bipolar Disorder Demystified. Cerrone Cohen, MD FABPN, FABFM Duke Departments of Family Medicine and Psychiatry

Kelly Godecke, MD Department of Psychiatry University of Utah

Treatment of Bipolar disorder

Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression

It's Cycling, Not Polarity Understanding and Diagnosing the Bipolar Spectrum

Mixing and Matching: Layering Medications as Family Physicians

Mood Disorders for Care Coordinators

The Pharmacological Management of Bipolar Disorder: An Update

CHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Treatment Options for Bipolar Disorder Contents

Clinical Guideline for the Management of Bipolar Disorder in Adults

PEDIATRIC BIPOLAR DISORDER

Bipolar Disorders. Disclosure Statement. I have no financial disclosures or conflicts of interest

Review Session 3. Case. Annemarie Mikowski DO Assistant Clinical Instructor Chief Resident Psychiatry

WHICH BIPOLAR MEDS TO USE IN PRIMARY CARE?

Bipolar Disorder 4/6/2014. Bipolar Disorder. Symptoms of Depression. Mania. Depression

Mood Disorders.

Things You Might Not Know About Psychotropic Medications But Wish You Did

35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child

Multistate Outcome Analysis of Treatment MOAT

Challenges in identifying and treating bipolar depression: a guide

BIPOLAR DISORDERS UPDATE. Anthony Archer, DO

Bipolar Disorder Michael Coudreaut, MD

Bipolar Disorder in Youth

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

PDF created with pdffactory Pro trial version

Aging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health

April 2016 Prepared By: Kimberly D. Griego, PharmD, CGP

CASE 5 - Toy & Klamen CASE FILES: Psychiatry

Drugs, Society and Behavior

HealthyPlace s Introductory Guide to Bipolar Disorder. By Natasha Tracy

Management of Bipolar Depression

Antipsychotics in Bipolar

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos.

Psychiatric Medications. Positive and negative effects in the classroom

Comparison of the Usefulness of Lithium and Valproate

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

5 COMMON QUESTIONS WHEN TREATING DEPRESSION

Improving the Recognition and Treatment of Bipolar Depression

Depression. University of Illinois at Chicago College of Nursing

ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN

Major Depressive Disorder (MDD) in Children under Age 6

Riding the Waves: Tools for the Management of Bipolar Disorder

What s new in the treatment of bipolar disorder?

September 26 28, 2013 Westin Tampa Harbour Island. Co-sponsored by

Your footnote

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula

Schedule FDA & literature based indications

Bipolar Disorder in Adults

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Pennsylvania Academy of Family Physicians Foundation & UPMC 43rd Refresher Course in Family Medicine CME Conference March 10-13, 2016

Affective Disorders.

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 18 February 2009

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

Antidepressant Medication Therapy in Primary Care July 25, 2013

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Criteria for Child Psychiatrist on the Use of Selected Psychotropic Medications in Children & Adolescents

Psychiatric Medication Guide

Steps for Initiating Electroconvulsive Therapy Treatment

Santa Clara County Mental Health Department Medication Practice Guidelines MOOD STABILIZERS

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010

Pediatric Bipolar Disorder

Medications and Children Disorders

Class Update: Oral Antipsychotics

Psychiatry Clinical Reviews Mania Matters

Bipolar Disorder. National Institute of Mental Health. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health

Care Manager Orientation to the Use of Psychiatric Medication

Major Depressive Disorder (MDD) in Children under Age 6

Roles of primary care physicians in managing bipolar disorders in adults

8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation

Depressive, Bipolar and Related Disorders

Psychiatry in Primary Care: What is the Role of Pharmacist?

Aggression (Severe) in Children under Age 6

Approach to Bipolar Disorder Family Medicine Forum November 14 17, 2018 Toronto, Ontario

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Bipolar Disorder Clinical Practice Guideline Summary for Primary Care

Disclosures. Objectives. Talk Overview 11/28/2016. Advanced Perinatal Pharamcology

Pediatric Psychopharmacology

Is Depression management getting you down? G. Michael Allan Director Programs and Practice Support, CFPC Professor, Family Med, U of A

Early Intervention in Bipolar Disorder Depends on Early Identification: Strategies for Optimizing Positive Outcomes

Practical Psychopharmacology for More Complex Mental Health Presentations

Psychotropic Strategies Handout Package

Practical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current Clinical Guidelines

Florida Best Practice Medication Guidelines Principles of Practice for Adults

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013

Crisis Intervention Team (CIT) Training

Bipolar treatment update

A Critical Review of. Current Guidelines for Bipolar Disorder. R. Hamish McAllister-Williams, MD, PhD, MRCPsych

Non-A, non-b=hcv; IFN/RBV; DSM-5/Ham-D, OLT; SSRI, P450

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

Ohio Psychotropic Medication Quality Improvement Collaborative. Minds Matter. Toolkit. for You and Your Family. This is the property of

Transcription:

Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences BIPOLAR DISORDERS DIAGNOSTIC AND TREATMENT ISSUES RICHARD RIES MD PROFESSOR DEPARTMENT OF PSYCHIATRY UNIVERSITY OF WASHINGTON HARBORVIEW MEDICAL CENTER RRIES@UW.EDU UW 1 PACC

RIES CONFLICT OF INTEREST STATEMENT Dr. Ries has Grant funding from: NIH- NIDA- NIMH Contingency Management Alcohol in Mentally Ill Preventing Addiction Related Suicide Prolonged Exposure +/_ Sertraline for Severe PTSD Suicide Prevention follow up study- AFSP Use of MAT for Opioid Dep in Primary care PTSD treatment in Heavy MJ users Dept of Defense Suicide prevention in troops Washington State Telemedicine Case Didactics and Case conferences on Psych/Addictions patients in Primary Care ()

JOANNE Complains of intense fatigue, depression, and sleeping 12+ hrs a day, but when awake feeling terrible anxiety and irritability, then not sleeping for 2 days. She has a history of 2 previous depressions and has been taking sertraline 200 mg a day. Family positive for alcohol in father and recurrent severe depression in mother, and grandmother who spent time in state hospital.

TIME SPENT IN SPECIFIC BIPOLAR DISORDER AFFECTIVE SYMPTOMS Bipolar I Patients 9% 6% % of Weeks Asymptomatic Bipolar II Patients 146 bipolar I patients followed 12.8 years 86 bipolar II patients followed 13.4 years 1% 2% 32% 53% Depressed Manic/hypomanic 50% 46%* Cycling/mixed Ratio of 3:1 Depressed vs Manic/hypomanic Ratio of 39:1 Depressed vs Hypomanic *%s do not add to 100 due to rounding Judd LL et al. Arch Gen Psychiatry. 2002;59:530 537. Judd LL et al. Arch Gen Psychiatry. 2003;60:261 269.

DIFFERENTIAL DIAGNOSIS: MDD OR BIPOLAR DISORDER? It may take up to 10 years or more for bipolar disorder to be accurately diagnosed and treated. Clues that your patient may have bipolar disorder 5. Associated Features Unevenness in intimate relationships Frequent career changes High prevalence of comorbidities (eg, substance use disorders) 4. Mania Symptoms Distractibility Decreased need for sleep Grandiosity / Flight of ideas / Racing thoughts Irritability / Risky behavior / Pressured speech Key Elements 1. Family History Higher rates of psychiatric illness Positive for bipolar disorder 2. Course of Illness Illness onset usually before age 25 Increased overall mood episodes Postpartum onset of depression Highly recurrent depressive episodes 3. Treatment Response Suboptimal outcome with antidepressants Antidepressant-induced manic switch Diagnostic and Statistical Manual of Mental Disorders, 4th ed, 2000. Hirschfeld RM et al. J Clin Psychiatry. 2003;64:161 174.

BIPOLAR MEDICATIONS TREATMENT: MOOD STABILIZERS Lithium* Bipolar 1 prevention Anticonvulants Depakote* (divalproex sodium) Lamictal* (lamotrigine)- Bipolar 2 prevention Tegretol (carbamazepine) Trileptal (oxcarbazepine) Neurontin (gabapentin)topamax (topiramate)keppra(levetiracetam) Atypical Antipsychotics Seroquel ( quetiapine) Latuda ( Lurasidone) Zyprexa ( Olanzapine) plus antidep. Abilify ( Aripiprazole) plus Mood stabilizer or antidep *FDA-approved

MOOD STABILIZERS: LITHIUM Advantages: 50+ years worldwide experience (FDA-approved 1970) effective in euphoric mania and hypomania inexpensive reduces suicide rate¹ ² Disadvantages: slow onset ~ 14 days narrow therapeutic index non-response in > 50% (usually bipolar subtypes) frequent side effects (polyuria, tremor, GI symptoms) and noncompliance discontinuation associated with high relapse rate³ ¹Baldessarini RJ, et al. J Clin Psychiatry. 2003;64 Suppl 5:44-52. ²Goodwin FK, et al. JAMA. 2003 Sep 17;290(11):1467-73. ³Cavanagh J, et al. Acta Psychiatr Scand. 2004 Feb;109(2):91-5.

MOOD STABILIZERS: DIVALPROEX Advantages: extensive experience (FDA-approved for epilepsy 1983; for bipolar mania 1995) rapid onset (1-4 days) loading dose strategy¹ well-tolerated: 20 mgs/kg 77% moderate to marked response effective in Bipolar subtypes effective for psychotic symptoms² plasma levels (50-125 mcg/ml) less cognitive impairment than lithium³ ¹McElroy SL, Keck PE. Neuropsychobiol. 1993;27(3):146-9. ²McElroy SL, et al. J Clin Psych. 1996 Apr;57(4):142-6. ³Zajecka J, et al. J Clin Psych. 1996 Aug;57(8):356-9.

MOOD STABILIZERS: DIVALPROEX Disadvantages: sedation transient hair loss weight gain tremor GI upset dose-related thrombocytopenia rare hepatotoxicity, pancreatitis possible Polycystic Ovarian Syndrome plasma level monitoring

MOOD STABILIZERS: LAMICTAL FDA-approved for maintenance treatment of Bipolar I Disorder Black box warning for serious rash (includes Stevens-Johnson Syndrome and toxic epidermal necrolysis) Slow titration necessary Interaction with other AEDs (especially valproic acid and carbamazepine)

LAMICTAL: EFFICACY IN BIPOLAR DISORDER Placebo controlled 18-month trials of lamotrigine and lithium pooled analysis 8-16 week open label treatment with lamotrigine or lithium before randomization: N = 191 for placebo N = 280 for lamotrigine (100-400 mgs/d) N = 167 for lithium (0.8-1.1 meq/l) 18-month maintenance treatment phase Both lamotrigine and lithium superior to placebo in preventing any mood episode Goodwin GM, et al;j Clin Psych 2004 Mar;65(3):432-441 Bowden CL, et al;arch Gen Psych 2003 Apr;60(4):392-400 Calabrese JR, et al;j Clin Psych 2003 Sep;64(9):1013-1024

WHAT ABOUT BIPOLAR MANIA + PSYCHOSIS MANAGEMENT Acute Antipsychotic + mood stabilizer + Benzo Example- Olanzapine 20 + Lithium 300 tid + Lorazepam 1 mg tid Subacute : lower Antipsychotic and the Benzo/ up the lithium, or change to Divalproex Longer term: Li 600 am and 900 pm with level 0.8 plus aripiprazole ( less sedating) or Loxapine 10 mg (more sedating) --- both metabolically lower risk

WHAT ABOUT SEVERE BIPOLAR DEPRESSIONS? Increase Lithium to near toxic levels (1.2) Add Lamotragine Bip 2 Add antidep (bupropion or SSRI) If bipolar 1 and has had full mania or psychosis in history, add antipsychotic before the antidepressant Example --Pt now on Lithium or Divalproate + Aripiprazole 15mg + Bupropion 300 mg Add Quetiapine (300 mg) or Lurasidone (40-120) Consider ECT in med resistant depressions

COMPARATIVE SIDE EFFECT PROFILE OF ATYPICAL NEUROLEPTICS AND BIPOLAR Drug: EPS: Weight Gain: Sedation: Prolactin: Aripiprazole 0/+ 0/+ 0/+ 0 Lurasidone 0/+ 0/+ 0/+ 0 Olanzapine ++ ++++ ++ ++ Quetiapine 0 ++ +++ 0 Risperidone +++ +++ + +++ Ziprasidone ++ 0/+ + +

IT MAY NOT BE THAT THE MED(S) STOPPED WORKING, BUT The patient stopped the med...or The patient stopped the med AND used drugs and/or alcohol... OR lowered the med and used OR used on top of the med. OR used twice the dose on one day and nothing the next. Stimulants (cocaine/amphets) are most MSE destructive, but alcohol most suicide related

WHAT ABOUT TALK THERAPY? J Affect Disord. 2016 Sep 1;201:203-14. doi: 10.1016/j.jad.2016.05.018. Epub 2016 May 14. Empirically supported psychosocial interventions for bipolar disorder: Current state of the research. Salcedo S 1, et al We conducted a search of the literature to examine recent (2007-present), randomized controlled studies All of the psychotherapy interventions appear to be effective in reducing depressive symptoms. Psychoeducation and CBT are associated with increased time to mood episode relapse or recurrence. MBCT ( mindfulness based) has demonstrated a particular effectiveness in improving depressive and anxiety symptoms. Online psychotherapy interventions, programs combining one or more psychotherapy interventions, and targeted interventions centering on particular symptoms have been the focus of recent, randomized controlled studies in bipolar disorder.

JOANNE ---BIPOLAR TID RECOVERY EXERCISE: LINKING BIO-PSYCHO-SOCIAL- Three x Three (TID) Times a Day: My Recovery Plan includes (Rx Plan) 1. seeing my prim care doc/nurse every 2 weeks, for now 2. taking my Bipolar meds and hypertension meds every day 3. power walking once a day In order to (Rx Goals) 1. get my health back 2. keep my family together 3. prevent another suicide attempt And Three things I am grateful for include: (Gratitude) 1. I have my family and job 2. Bipolar meds work if you take them and don t drink 3. I am way better than last Spring there is Hope

CASE PRESENTATION George is a 32 yo single primary care patient who recently joined your practice. His physical exam and screening labs are normal other than slight hyperlipidemia. His mental status is normal. History reveals that George has had previous treatment for depression with a hospitalization in California 3 years ago and outpatient treatment 5 years ago. He does not remember the medications he took 5 years ago, but says he gradually got better. When he was hospitalized he was treated with Venlafaxine 300 mg and clonazepam 2 mg a day which he has continued.

GEORGE His primary care doctor asks about why he was taking the clonazepam, and George says it was because that while his depression eventually got better, he also became so agitated that he needed it, however several other doctors have not wanted to prescribe this, and he is also concerned about dependence on it. George tells you that he thinks he might be bipolar because he took an online test and his score indicated that he was bipolar. Family history indicates a brother with recurrent depressions and homelessness, who at times acts very strangely What should his primary care doctor do?